Update: consequences of abnormal fetal growth

Area of Science:

• Pediatrics
• Endocrinology
• Developmental Biology

Background:

• Intrauterine growth restriction (IUGR) is a global health concern with lasting effects.
• Children born small for gestational age face increased risks of type 2 diabetes, metabolic syndrome, and cardiovascular disease.
• Metabolic consequences of IUGR are evident early, persist with age, and are worsened by adiposity.

Purpose of the Study:

• To review the literature on the long-term metabolic effects of Intrauterine growth restriction (IUGR).
• To explore the mechanisms underlying metabolic programming in IUGR.
• To identify potential epigenetic signatures associated with IUGR.

Main Methods:

• Literature review of recent studies on Intrauterine growth restriction (IUGR).
• Analysis of the impact of early growth patterns on later health outcomes.
• Exploration of epigenetic modifications, specifically DNA methylation, in IUGR.

Main Results:

• Metabolic effects of being born small for gestational age are evident in early childhood and persist throughout life.
• Rapid weight gain in early childhood amplifies the risk of future metabolic dysfunction.
• Exogenous human GH treatment shows variable efficacy in improving height for children born small for gestational age.

Conclusions:

• Intrauterine growth restriction (IUGR) leads to widespread epigenetic changes, including DNA methylation alterations.
• Identifying specific epigenetic signatures for IUGR is a critical research frontier.
• Linking epigenetic alterations to gene expression and adult metabolic abnormalities is essential for understanding IUGR's long-term impact.